PacBio Launches HiFiViral SARS-CoV-2 Kit and Microbial Whole Genome Sequencing Enhancements to Combat Infectious Disease and Strengthen Public Health Response to Pathogen Threats
Go back to PacBio Launches HiFiViral SARS-CoV-2 Kit and Microbial Whole Genome Sequencing Enhancements to Combat Infectious Disease and Strengthen Public Health Response to Pathogen Threats| PACIFIC BIO CA (NASDAQ: PACB) | Delayed: 5.73 +0.22 (3.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.51 | 52 Week High | $14.00 | |||
| Open | $5.68 | 52 Week Low | $6.61 | |||
| Day High | $5.94 | P/E | N/A | |||
| Day Low | $5.46 | EPS | $-1.26 | |||
| Volume | 4,479,697 | |||||
